These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 29914894)

  • 1. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

  • 2. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
    Zhao X; Cheng Z; Wang J
    Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA FEZF1-AS1 in human cancers.
    Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
    Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.
    Chen N; Guo D; Xu Q; Yang M; Wang D; Peng M; Ding Y; Wang S; Zhou J
    Oncotarget; 2016 Mar; 7(10):11271-83. PubMed ID: 26848625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
    Zhu LF; Song LD; Xu Q; Zhan JF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
    Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
    Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis.
    Li QY; Chen L; Hu N; Zhao H
    Biomed Pharmacother; 2018 Jul; 103():1727-1732. PubMed ID: 29864963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
    Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
    Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
    Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
    Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
    Zhang T; Yu S; Zhao S
    Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
    Liu Z; Wang N; Wang F; Zhang S; Ding J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer.
    Mo S; Zhang L; Dai W; Han L; Wang R; Xiang W; Wang Z; Li Q; Yu J; Yuan J; Cai S; Cai G
    Cell Death Dis; 2020 Feb; 11(2):155. PubMed ID: 32111819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.